GENIX PHARMACEUTICALS CORP (GENX.CA) Stock Analyst Earnings Estimates
TSX-V:GENX - TSX Venture Exchange - CA37232A1093 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 12.4K | |||
| EBITDA YoY % growth | -1.12M -216.27% | -468.4K 58.17% | -334.8K 28.52% | |
| EBIT YoY % growth | -1.657M -131.45% | -1.033M 37.66% | -882.2K 14.57% | |
| Operating Margin | N/A | N/A | -7,114.52% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1K -62.96% | % | ||
| Q2 2024 Q2Q % growth | 2.9K -64.20% | % | ||
| Q1 2024 Q2Q % growth | 100 -93.75% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | -100.00% | % | ||
| Q1 2020 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |